Abstract:Mycobacterium tuberculosis is an organism that causes tuberculosis (TB), a common infectious disease that has a high death and morbidity rate. Topological indices are mathematical tools used to describe the structural properties of molecules or networks. They provide a quantitative measure of the connectivity and complexity of a system, and play a crucial role in numerous area such as biochemistry and bioinformatics. The purpose of topological indices is to simplify complex structures into numerical values that can be easily analyzed and compared. QSPR modeling is a technique in chemistry that relates the structure of a chemical compound to its physical or chemical properties. It is used to predict properties like boiling points, solubilities, toxicities, and even biological activities of compounds. This saves time, resources, and enables researchers to make informed decisions in drug discovery, material science, and many other areas. In this study, we conducted an analysis of several drugs used for the treatment of tuberculosis. We focused on computing the reducible topological indices based on their degrees. Several techniques and approaches are employed. To perform calculations, we used edge partition methodology, analytical techniques, theoretical graph utilities, and degree counting method. Additionally, we examined six physicochemical properties of these drugs. To establish quantitative structure-property relationship models and evaluate their effectiveness, we employed linear, quadratic, and logarithmic regression analysis. By analyzing the reducible topological indices and physicochemical properties, we aimed to gain a deeper understanding of the drugs' characteristics and their potential impact on tuberculosis treatment. This study established a significant relationship between the defined indices with two key properties: molar mass and collision cross section. The correlation coefficients for molar mass range from 0.7 to 0.9, while the collision cross section range from 0.8 to 0.9. These results demonstrate a strong association between the indices and the properties under investigation. Furthermore, it is worth noting that both molar mass and collision cross section satisfy the requirements for p -value and F -test value across all indices. This indicates the statistical significance of the observed correlations and the reliability of our findings.

Predictive Comparative QSAR analysis of Sulfathiazole Analogues as Mycobacterium Tuberculosis H37RV Inhabitors

Predictive Comparative QSAR Analysis Of As 5-Nitofuran-2-YL Derivatives Myco bacterium tuberculosis H37RV Inhibitors Bacterium Tuberculosis H37RV Inhibitors

QSAR Modeling, Molecular Docking and ADMET Study of Aryl Fluorosulfate Derivatives as Potential Anti-TB Agents

The systematic modeling studies and free energy calculations of the phenazine compounds as anti-tuberculosis agents

Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Analyzing the role of reducible molecular descriptors and thermodynamic aspects of anti-tuberculosis drugs via QSPR study

3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase

Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies

Ligand-based virtual screening and biological evaluation of inhibitors of Mycobacterium tuberculosis H37Rv

In silico identification of phytochemical inhibitors for multidrug-resistant tuberculosis based on novel pharmacophore generation and molecular dynamics simulation studies

Exploring the properties of antituberculosis drugs through QSPR graph models and domination-based topological descriptors

Important Molecular Descriptors Selection Using Self Tuned Reweighted Sampling Method for Prediction of Antituberculosis Activity

In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions

Design, synthesis, anti-tubercular activity, and computational studies of novel 3-(quinolin-3-yl)-1-phenylprop-2-en-1-one derivatives

Computational investigation on the anti-tuberculosis potential of novel thiazinane derivatives

Pyrrole‐Thiazolidin‐4‐one Analogues Exhibit Promising Anti‐Tuberculosis Activity

In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis

Chemical synthesis and molecular modeling of novel substituted N-1,3-benzoxazol-2yl benzene sulfonamides as inhibitors of inhA enzyme and Mycobacterium tuberculosis growth

Synthesis, antimycobacterial screening, molecular docking, ADMET prediction and pharmacological evaluation on novel pyran-4-one bearing hydrazone, triazole and isoxazole moieties: Potential inhibitors of SARS CoV-2

3D-QSAR and ADMET studies of morpholino-pyrimidine inhibitors of DprE1 from Mycobacterium tuberculosis

In-silico studies of anti-tuberculosis drugs using advanced computational techniques